European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on August 25, 2026

Aug. 25, 2026

First Atlantic Nickel & Cobalt Attends the Defense Industrial Base Accelerator (DIBX) 2026, Showcasing Awaruite (Ni-Fe-Co Alloy) Samples Processed with ONSHORE MAX™ Into an Alloy Concentrate Up to 71.9% Nickel and 1.76% Cobalt from the Pipestone XL…

Indeterminate GlobeNewswire

Aug. 25, 2026

Astrocyte Pharmaceuticals Receives NIH Award to Evaluate AST-004 in Substance Use Disorders

Indeterminate GlobeNewswire

Aug. 25, 2026

Transaction in Own Shares

Indeterminate GlobeNewswire

Aug. 25, 2026

Revier Therapeutics startet mit 6 Mio. € Seed-Finanzierung zur Entwicklung von Klasse-IIa-HDAC-Inhibitoren für kardiometabolische Erkrankungen

Indeterminate GlobeNewswire

Aug. 25, 2026

Revier Therapeutics Launches with €6 Million Seed Financing to Pioneer Class IIa HDAC Inhibitors for Cardiometabolic Disease

Indeterminate GlobeNewswire

Aug. 25, 2026

OpenTitan project kicks off the Peppermint integrated root-of-trust for area-constrained SoCs

Indeterminate GlobeNewswire

Aug. 25, 2026

PO Wealth Sharing Group Introduces Data-Driven Framework for U.S. Stock Market Analysis

Indeterminate GlobeNewswire

Aug. 25, 2026

Einride Scales Electric Freight Operations with Lidl in Sweden

Indeterminate GlobeNewswire

Aug. 25, 2026

ING announces change in Supervisory Board

Indeterminate GlobeNewswire

Aug. 25, 2026

Progress on share buyback programme

Indeterminate GlobeNewswire

Aug. 25, 2026

Cofiroute selects TomTom Traffic to enhance real-time motorway operations and driver information

Indeterminate GlobeNewswire

Aug. 25, 2026

ISS expands partnership with multinational customer

Indeterminate GlobeNewswire

Aug. 25, 2026

Greenland Mines Sarfartoq Nd-Pr Rare Earth Project Valued Up to US$2.05 Billion With Pre-Tax IRR of 118.6% and Significant Additional Upside Potential

Indeterminate GlobeNewswire

Aug. 25, 2026

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage

Indeterminate GlobeNewswire

Aug. 25, 2026

Helium Evolution Closes $25 Million Private Placement

Indeterminate GlobeNewswire